Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neutralizing SARS-CoV-2.

eLife - 15 Dec 2020

Poeschla Eric

Abstract excerpt

Experiments with hybrid viruses are illuminating how SARS-CoV-2 can escape neutralizing antibodies.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Neutralizing
Share to Antibodies, Viral
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Vaccines

Share to Evolution, Molecular

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 33320086
DOI: 10.7554/eLife.64496
PMCID: PMC7738179

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neutralizing SARS-CoV-2.PMID 33320086Read ↗

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesSemantic proximity Read ↗

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2Semantic proximity Read ↗

Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2Semantic proximity Read ↗

Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic testSemantic proximity Read ↗

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Semantic proximity Read ↗

SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1Semantic proximity Read ↗

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationSemantic proximity Read ↗

Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations.Semantic proximity Read ↗

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsSemantic proximity Read ↗

A <i>Trans</i>-Complementation System for SARS-CoV-2Semantic proximity Read ↗

A <i>trans</i> -complementation system for SARS-CoV-2Semantic proximity Read ↗

Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.